Lupeng Pharmaceutical's rocbrutinib receives Chinese approval to treat R/R mantle cell lymphoma
Medtronic invests in ICE technology companies to expand cardiac ablation portfolio
Heart Rhythm Society partners with Milestone Pharmaceuticals to offer new SVT patient resources
Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026
Circio and AaviGen partner to develop next-generation gene therapies for heart disease
Eli Lilly reports positive Phase 1b results for VERVE-102
Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension
GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49
Tenaya Therapeutics reports interim RIDGE-1 data showing reduced arrhythmia burden with TN-401
AnaCardio reports Phase 1b/2a data showing cardiac function gains with AC01
Veradermics reports positive Phase 2/3 results for oral VDPHL01 in pattern hair loss treatment